Rare Case of Periampullary Duodenal Carcinoma

Desi Maghfirah, Azzaki Abubakar, Fauzi Yusuf, Muhammad Riswan


Periampullary carcinoma is a malignancy that appears around the vatteri ampulla. This malignancy can originate from the pancreas, duodenum, and distal choledochal duct. Duodenal cancer is a very rare case, only about 0.3% of the gastrointestinal malignancies. Reported cases are increasing with the increasing use of esophagogastroduodenoscopy. The most frequently found carcinomas of the duodenum include adenocarcinoma, carcinoid, lymphoma, and leiomyosarcoma. The symptoms of these carcinomas are often not specific so the diagnosis is often late, leading to a poor prognosis. Early diagnosis and proper therapy provide a good prognosis.  The case reported here representeda 52-year-old woman presented with hematemesis melena, anemia, jaundice, epigastric mass, right hypochondrial pain, and weight loss. From the esophagogastroduodenoscopy, the mass was found to obstruct half of the duodenum lumen and bleeding, which was easily triggered, was observed in the second part of the duodenum. CT scan revealed a mass in the head of the pancreas with gall bladder hydrops and obstruction of the intra and extra-hepatic billier system. After a Whipple operation Laparotomy, the histology showed papillary adenocarcinoma duodenum. Patients then underwen chemotherapy with 5 fluorouracil regimen. Patient's clinical condition is currently improving and no complaint is conveyed by the patient.


Adenocarninoma, duodenal carcinoma periampullary, whipple

Full Text:



Velandia C, Morales RD, Coello C, Mendoza AG, Pérez G, Aguero E. Neoadjuvant chemotherapy in locally advanced duodenal adenocarcinoma. Ecancermedicalscience. 2018;12:816.

Han SL, Cheng J, Zhou HZ, Zeng QQ LS. The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Cancer. 2010;12(4):243–7.

Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, et al. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer. World J Gastrointest Oncol. 2017;9(10):407–15.

Sista F, Santis G De, Giuliani A, Cecilia EM, Piccione F, Leardi S, et al. Adenocarcinoma of the third duodenal portion : Case report and review of literature. World J Gastrointest Surg. 2012;4(1):23–6.

Chung WC, Paik CN, Jung SH, Lee K, Kim SW, Chang U. Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma. Korean J Intern Med. 2011; 26(1):34–40.

John PK, Kougioumtzopoulou AS, Syrigos KN, Saif MW. Updates in management of ampullary carcinomas updates in management of ampullary carcinomas. J Pancreas. 2014;15(2):140–3.

Mayer RJ. Gastrointestinal tract cancer. In: Harrison’s Principles of Internal Medicine. 18th ed. New York: The McGraw-Hill Companies.Inc.; 2011. p. 774–5.

Ludwig E KR. Tumor of the small intestine. In: gastrointestinal and liver disease pathophysiology Diagnosis Management. Elsevier Inc.; 2010. p. 2145–53.

Han S, Cheng J, Zhou H, Guo S, Jia Z, Wang P. Surgically treated primary malignant tumor of small bowel: A clinical analysis. World J Gastroenterol. 2010;16(12):1527–32.

He C, Mao Y, Wang J, Huang X, Lin X, Li S. Surgical management of periampullary adenocarcinoma: defining an optimal prognostic lymph node stratification schema. J Cancer. 2018; 9(9):1667–79.

Gaspar B, Beuran M, Paun S, Ganescu R, Hostiuc S, Negoi I. Current strategies in the therapeutic approach for adenocarcinoma of the ampulla of Vater. J Med Life. 2013;6(3):260–5.

Lundgren S, Elebro J, Heby M, Karnevi E. Mutational landscape in resected periampullary adenocarcinoma : relationship with morphology and clinical outcome. JCO Precis Oncol. 2019;3:1–8.

Meijer LL, Alberga AJ, Bakker JK De, Vliet HJ Van Der, Large TYS Le, Grieken NCT Van, et al. Outcomes and treatment options for duodenal adenocarcinoma : a systematic review and meta-analysis. Ann Surg Oncol. 2018;25(9):2681–92.

Zaanan A, Costes L, Gauthier M, Malka D, Locher C, Mitry E, et al. Chemotherapy of advanced small-bowel adenocarcinoma : a multicenter AGEO study. Ann Oncol. 2010;21(9):1786–93.

Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. Philadelpia: Lippincott Raven Publishers; 2010. p 127–9.

Fazl QP, Mozzain IK, Shakeel RK, Mubashir AS, Sajjad AD, Abdul Rashid L, et al. Periampullary carcinoma-a rare histopathological variant case report periampullary carcinoma-a rare histopathological variant. J Pancreat Cancer. 2021;7(1):1–7.

Williams JL, Chan CK, Toste PA, Elliott IA, Vasquez CR, Sunjaya DB, et al. Association of histopathologic phenotype of periampullary. JAMA Surg. 2017;152(1):82–8.

He C, Mao Y, Wang J, Duan F, Lin X, Li S. Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy. BMC Cancer; 2018;18(327):1–11.

Ramfidis VS, Syrigos KN, Saif MW. Ampullary and periampullary adenocarcinoma: new challenges in management of recurrence. J Pancreas. 2013;14(2):158–60.

Elebro J. Prognostic factors in periampullary adenocarcinoma A retrospective study over an 11 year period. Lund University, Faculty of Medicine Doctoral Dissertation Series 2016:48. p. 11–65.

DOI: https://doi.org/10.15395/mkb.v53n1.1988

Article Metrics

Abstract view : 427 times
PDF - 323 times

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Creative Commons License
MKB is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License


View My Stats